PerkinElmer, Inc. (PKI) News

PerkinElmer, Inc. (PKI)

Today's Latest Price: $124.45 USD

0.75 (-0.60%)

Updated Oct 23 7:00pm

Add PKI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

Filter PKI News Items

PKI News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest PKI News From Around the Web

Below are the latest news stories about Perkinelmer Inc that investors may wish to consider to help them evaluate PKI as an investment opportunity.

Immunohistochemistry Market To Witness Steady Growth With Danaher, Merck KGaA, Thermo Fisher Scientific, PerkinElmer, Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signalling Technology and F. Hoffmann-La Roche among others

A report by The Insight Partner's on the Immunohistochemistry Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market

OpenPR | October 1, 2020

Global Medical Optical Imaging System Market Report Covers Growing Strategies Used By Top Key Players || Natus Medical, Inc., PerkinElmer, Inc.

The motive of this strategic research report entitled Global Medical Optical Imaging System Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global

OpenPR | September 30, 2020

Gene Expression Market Reflect a Holistic Expansion With Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Bio-Rad Laboratories, OriGene Technologies, Illumina, Inc., QIAGEN

A report by The Insight Partner's on the Gene Expression Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the

OpenPR | September 29, 2020

COVID-19 Creates A Windfall For PerkinElmer, And Some Of The Benefits May Linger

It may be indelicate to talk about beneficiaries of a deadly global pandemic, but the reality is that COVID-19 has created an unexpected surge in business for many life sciences companies. In the case of PerkinElmer (PKI), while the recent demand for real-time PCR workstations and kits, liquid handling systems,...

Stephen Simpson, CFA on Seeking Alpha | September 28, 2020

PerkinElmer launches Solus Listeria monocytogenes ELISA assay

PerkinElmer, Inc. has launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay.

Dairy Reporter | September 22, 2020

PerkinElmer Launches DA 7350™ Instrument and Cloud-Based Software for Quality Control in Food Production

WALTHAM, Mass.--(BUSINESS WIRE)--Today PerkinElmer introduces the DA 7350 instrument and software providing continuous quality control testing for food manufacturing processes.

Business Wire | September 15, 2020

Needham upgrade lifts PerkinElmer; shares up 4%

Needham has upgraded PerkinElmer ([[PKI]] +4.0%) to Buy from Hold with a $139 price target (17% upside), also adding the stock to his Conviction Buy list.The analyst is impressed with the "strong operational performance" of the company's Diagnostics segment as the company reported almost doubled earnings in Q2.The company said...

Seeking Alpha | September 11, 2020

Newsom announces partnership with PerkinElmer to more than double California COVID testing capacity

Diagnostic testing and imaging company PerkinElmer will build a new laboratory in California that will allow the state to more than double its COVID-19 testing capacity by November.

SFGate | August 26, 2020

Can PerkinElmer (PKI) Run Higher on Rising Earnings Estimates?

PerkinElmer (PKI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Yahoo | July 30, 2020

PerkinElmer's (PKI) CEO Prahlad Singh on Q2 2020 Results - Earnings Call Transcript

PerkinElmer, Inc. (PKI) Q2 2020 Earnings Conference Call July 28, 2020 5:00 PM ET Company Participants Bryan Kipp – Vice President-Investor Relations Prahlad Singh – President and Chief Executive Officer Jamey Mock – Senior Vice President and Chief Financial Officer Conference Call Participants Vijay Kumar – Evercore Steve Willoughby –...

SA Transcripts on Seeking Alpha | July 29, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5802 seconds.